Healthcare Industry News: SynCardia Systems
News Release - October 12, 2010
Italian Man Surpasses 1,000 Days of Support with SynCardia’s Total Artificial Heart54-Year-Old Man Enjoys Life at Home with Portable Driver While Waiting for a Matching Donor Heart
TUCSON, Ariz.--(Healthcare Sales & Marketing Network)-- A 54-year-old Italian man has become the first patient to surpass 1,000 days of support with the SynCardia temporary Total Artificial Heart while waiting for a matching donor heart.
“Life is a wonderful present that has to be respected,” said Total Artificial Heart patient Pietro Zorzetto. “The Total Artificial Heart allowed me to recover to a very healthy physical condition. I really want to thank the SynCardia Total Artificial Heart for these unexpected 1,000 days of life.”
Mr. Zorzetto was first admitted to Azienda Ospedaliera di Padova on Nov. 30, 2007, suffering from valvular cardiomyopathy. Two previous operations at a different hospital had failed to repair his failing heart. Less than a week later, on Dec. 6, 2007, Mr. Zorzetto made history when he became the first patient in Italy to be implanted with the SynCardia Total Artificial Heart.
“The Total Artificial Heart provides excellent cardiac output, which restored our patient to normal condition despite the fact he presented with severe multi-organ failure,” said Prof. Gino Gerosa. “The Total Artificial Heart in combination with the portable driver has been extremely effective in providing the patient with a good quality of life with excellent exercise capacity.”
Mr. Zorzetto has been enjoying life at home since Feb. 4, 2008, when he was discharged from the hospital using a portable driver to power his Total Artificial Heart. On a typical day, he walks 10 km and then exercises for an additional 30 minutes in his gym at home to stay in shape for a transplant.
CAUTION - The Freedom™ portable driver is CE approved for commercial use in Europe and is undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
About SynCardia Systems, Inc.
SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart. There have been more than 850 implants of the Total Artificial Heart, accounting for more than 200 patient years of life on the device.
Originally used as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end-stage biventricular failure. The Total Artificial Heart is the only device that provides immediate, safe blood flow of up to 9.5 L/min through both ventricles.
For additional information, please visit: http://www.syncardia.com or follow SynCardia on Twitter – @SynCardia_News
Source: SynCardia Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.